TRIPS, WTO and IPR: Impact of Indian Patent Act 2005 on Indian Pharmaceutical Industry
M D Nair
Abstract
M D Nair
Abstract
The World Trade Organization (WTO) was set up in 1995 and has been the custodian of all matters related to the implementation of the TRIPS Agreement endorsed by 153 member countries. WTO is therefore the most important body which monitors and influences working of global intellectual property rights protection in all its member countries. This opinion discusses the impact of Indian Patent Act 2005 on Indian pharmaceutical industry.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The World Trade Organization (WTO) was set up in 1995 and has been the custodian of all matters related to the implementation of the TRIPS Agreement endorsed by 153 member countries. WTO is therefore the most important body which monitors and influences working of global intellectual property rights protection in all its member countries. This opinion discusses the impact of Indian Patent Act 2005 on Indian pharmaceutical industry.
Key concepts: Intellectual property, TRIPS architecture, International trade, World trade, TRIPS Agreement, Business, Pharmaceutical industry, Access to medicines